Golimumab Tapering Strategy Based on Serum Drug Levels in Patients With Spondyloarthritis-Reference-Cited by-同舟云学术

Golimumab Tapering Strategy Based on Serum Drug Levels in Patients With Spondyloarthritis

Published:2018-07-02 Issue:8 Volume:70 Page:1356-1358
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Redondo Cristina¹,Martínez-Feito Ana¹,Plasencia-Rodríguez Chamaida¹,Navarro-Compán Victoria¹,Nuño-Nuño Laura¹,Peiteado Diana¹,Villalba Alejandro¹,Jochems Andrea¹,Pascual-Salcedo Dora¹,Balsa Alejandro¹

Affiliation:

1. La Paz University Hospital; Madrid Spain

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40542/fullpdf

Reference12 articles.

1. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials;Toussirot;Drug Des Devel Ther,2016

2. Drug trough levels predict therapeutic responses to dose reduction of adalimumab for rheumatoid arthritis patients during 24 weeks of follow-up;Chen;Rheumatology (Oxford),2016

3. Key findings towards optimising adalimumab treatment: the concentration-effect curve;Pouw;Ann Rheum Dis,2015

4. Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity;Plasencia;Clin Exp Rheumatol,2016

5. Immunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatment;Chen;Ann Rheum Dis,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-tailored dose reduction of tumor necrosis factor inhibitors in axial spondyloarthritis;International Immunopharmacology;2023-03

2. Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider;RMD Open;2022-06

3. The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019;Advances in Rheumatology;2020-02-21